General
FDA approves Lilly pill for common advanced breast cancer
 

FDA approves Lilly pill for common advanced breast cancer

Shared by:

 
Verzenio was approved Thursday by the Food and Drug Administration for HR-positive, HER2-negative breast cancer that has worsened after hormone therapy.
 
www.statnews.com
 
3 Oct 2017 - General